购物车
全部删除
您的购物车当前为空
别名 3,3'-[2,6-吡啶二基二(羰基亚氨基)]二[1-甲基喹啉鎓]
360A 是一种稳定的G-四链体配体,还抑制 TRAP-G4 试验中端粒酶的端粒酶活性,IC50值为 300 nM。

360A 是一种稳定的G-四链体配体,还抑制 TRAP-G4 试验中端粒酶的端粒酶活性,IC50值为 300 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 935 | 现货 | |
| 2 mg | ¥ 1,490 | 现货 | |
| 5 mg | ¥ 2,130 | 现货 | |
| 10 mg | ¥ 3,260 | 现货 | |
| 25 mg | ¥ 5,330 | 现货 | |
| 50 mg | ¥ 7,520 | 现货 | |
| 100 mg | ¥ 9,870 | 现货 |
| 产品描述 | 360A is a stabilizing G-Quadruplex ligand, and also inhibits telomerase activity for telomerase in TRAP-G4 assay(IC50 : 300 nM). |
| 靶点活性 | Telomerase:300 nM |
| 体外活性 | 向A549肺癌细胞系处理5 μM 360A,可以在11天的治疗内抑制细胞增殖。使用新合成的二聚体(360A)2A处理,产生了相当的抗增殖效果[1]。 |
| 细胞实验 | Supplemented with 10% fetal calf serum (FCS) and 1% penicillin/streptomycin. A549 cells were maintained in humidified incubators at 37 °C in an atmosphere containing 5% CO2 and ambient oxygen of 20%. Cells were grown in 25 cm^2 flasks (150,000 cells/flask) and treated with 5 μM of 360A or (360A)2A every 3 or 4 days (i.e., at each reseeding) until cultures were terminated. Control cells were either non-treated or treated with 0.1% DMSO. At each reseeding the remaining cells were pelleted and snap frozen for further DNA extraction.Statistical analysis was performed using GraphPad Prism 5. A Chi-square test was used to compare TDEs frequencies[1]. |
| 别名 | 3,3'-[2,6-吡啶二基二(羰基亚氨基)]二[1-甲基喹啉鎓] |
| 分子量 | 449.5 |
| 分子式 | C27H23N5O2 |
| CAS No. | 794458-56-3 |
| Smiles | C[N+]=1C2=C(C=C(NC(=O)C=3N=C(C(NC4=CC5=C([N+](C)=C4)C=CC=C5)=O)C=CC3)C1)C=CC=C2 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: Slightly soluble |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多